BeOne Medicines
ONC
#533
Rank
S$58.95 B
Marketcap
S$516.11
Share price
-0.97%
Change (1 day)
11.70%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): S$10.52

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is S$10.58. In 2025 the company made an earnings per share (EPS) of S$3.53 an increase over its 2024 EPS that were of S-$8.06.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$10.52198.35%
2025S$3.53-143.75%
2024S-$8.06
2022S-$25.1828.21%
2021S-$19.64-19.96%
2020S-$24.5420.81%
2019S-$20.3131.52%
2018S-$15.44417.57%
2017S-$2.98-37.16%
2016S-$4.75158.95%
2015S-$1.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.25-102.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.23-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA